Therapeutics | search
Click here to view Therapeutics news from 60+ newspapers.
Bookmark or Share- Santa Ana BioSanta Ana Bio is a precision immunology company leveraging multi-omics platforms and antibody engineering to deliver targeted therapies to patients with autoimmune and inflammatory diseases. Whole-section single cell profiling in Hidradenitis Suppurativa.
- News — Santa Ana BioSanta Ana: Leveraging human multi-omic data for precision immunology
- Santa Ana Bio - Crunchbase Company Profile & FundingSanta Ana Bio is a biotechnology company that leverages deep cell profiling technologies to design precision biologics in the autoimmune space. The company utilizes multi-omics platforms and antibody engineering to develop targeted therapies for patients with autoimmune and inflammatory diseases.
- Pipeline - Santa Ana BioAt Santa Ana Bio we are developing novel therapeutics including monoclonals, bi-specifics and antibody drug conjugates to treat patients with serious immune mediated diseases. SAB01 inhibits c-Kit, a validated target on the mast cells that drive a variety of allergic diseases.
- Santa Ana Bio, Inc. | LinkedInPrecision medicines for serious immune mediated diseases. | Santa Ana Bio is a Bay Area biotech focused on leveraging it’s multiomics and protein engineering platforms to design precision...
More
